share_log

Mizuho Maintains Neutral on Corvus Pharma, Maintains $3.5 Price Target

Moomoo 24/7 ·  Mar 27 13:21

Mizuho analyst Graig Suvannavejh maintains Corvus Pharma (NASDAQ:CRVS) with a Neutral and maintains $3.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment